Profiles in Legal Advice - February 16, 2017
From regulator to pharma industry specialist
Dr. Thomas Lönngren, former head of the EMA and today a pharmaceutical consultant, provides some insights on the aftermath of Brexit, describes current challenges the industry is facing and takes a short walk down memory lane on his career journey. The summer of 2016 will be remembered for many things; record temperatures, terrorist acts in […]
Pharma Business - September 5, 2016
Thomas Lönngren’s five pharma challenges
In our upcoming issue of Nordic Life Science, Thomas Lönngren, former head of the EMA, emphasizes five important hurdles to identify for the pharmaceutical sector. Thomas Lönngren’s years from the regulatory side and the last ten years as a consultant have provided him with a proper global overview of what the pharmaceutical sector is facing. […]